TLRY Stock Jumps On Revenue Beat, International Growth – Retail Eyes ‘Upside Reversal’ After 30% Slide This Year

• Tilray’s Q3 cannabis revenue climbed 19%, supported by a sharp 73% surge in international sales.
• The firm’s net loss narrowed significantly to $0.24 per share but fell below Street estimates.
• Tilray reaffirmed its FY2026 EBITDA outlook of $62 - $72 million.

Shares of Tilray Brands, Inc. (TLRY) jumped 4% on Wednesday after the company delivered a record third-quarter revenue, fueled by strong momentum in its international cannabis business.

Retail sentiment for TLRY on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes.

Q3 Revenue Beats Street Estimates

Tilray reported an 11% increase in third-quarter (Q3) revenue to $206.7 million, beating Wall Street’s estimates of $201.3 million, according to Fiscal.ai data. Growth was primarily driven by its cannabis and distribution segments.

Cannabis revenue climbed 19% to $64.8 million, supported by a sharp 73% jump in international sales. The company’s distribution net revenue, which includes Tilray Pharma, grew 34% to $83 million.

Tilray’s net loss narrowed significantly to $25.2 million from $793.5 million a year earlier, while loss per share improved to $0.24 from $8.69. However, this fell short of consensus estimates of $0.14.

The company’s balance sheet strengthened, shifting to a net cash position of $3.5 million from a net debt position of $36.6 million last year. Tilray also reaffirmed its full-year 2026 adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) outlook between $62 million and $72 million.

Tilray Bullish On Beverage Segment Despite Revenue Decline

Tilray’s revenue from its beverages business fell around 24% to $42.6 million in Q3, but management remained bullish on international expansion.

“With the acquisition of BrewDog, the UK’s leading craft beer brand, and our recently announced partnership with Carlsberg beginning in 2027, we are accelerating the buildout of a scaled global beverage platform. These initiatives broaden our infrastructure, strengthen our brand portfolio, and enhance our distribution capabilities, positioning Tilray to capture growth across key markets in the U.S., Europe, the Middle East, Australia, and Asia-Pacific,” said Irwin D. Simon, Chairman and CEO.

Tilray acquired BrewDog in March after signing an exclusive licensing agreement with the Carlsberg Group a month earlier.

What Did Retail Traders Say?

Chatter was mixed. One user said the stock is overdue for an “upside reversal” after the earnings report. The stock has crashed nearly 30% so far this year.

Another user said the revenue beat doesn’t matter since the company is “burning money.”

Retail investors are also keeping an eye on updates from Washington’s review of the Food and Drug Administration (FDA)’s proposed CBD compliance rule.

Read also: NIO, XPEV, LI Stocks Rally Pre-Market On Delivery Rebound In March – Even As Tesla Braces For Slower Quarter

For updates and corrections, email newsroom[at]stocktwits[dot]com.